The University of Miami Leonard M. Miller School of Medicine is the graduate medical school of the University of Miami. Founded in 1952, it is the oldest medical school in the state of Florida.

During the past decade, ISCI/University of Miami Miller School of Medicine conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ISCI/University of Miami Miller School of Medicine" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "The Emmes Company, LLC" with 2 trials as a collaborator, "Aldagen" with 1 trials as a collaborator, "Center for Cell and Gene Therapy, Baylor College of Medicine" with 1 trials as a collaborator and "The Marcus Foundation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "ISCI/University of Miami Miller School of Medicine" are "Chronic Ischemic Left Ventricular Dysfunction" (2 trials), "Myocardial Infarction" (2 trials), "Aging Frailty" (1 trials), "Back Pain" (1 trials) and "Cardiomyopathies" (1 trials). Many other conditions were trialed in "ISCI/University of Miami Miller School of Medicine" in a lesser frequency.

Most popular intervention types in "ISCI/University of Miami Miller School of Medicine" are "Biological" (6 trials), "Drug" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "ALD-301" (1 trials), "Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)" (1 trials), "Allogeneic Human Mesenchymal Stem Cells (hMSCs)" (1 trials) and "Allogeneic hMSCs" (1 trials). Other intervention names were less common.

The vast majority of trials in "ISCI/University of Miami Miller School of Medicine" are 8 trials for "All" genders.

Currently, there are NaN active trials in "ISCI/University of Miami Miller School of Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in ISCI/University of Miami Miller School of Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ISCI/University of Miami Miller School of Medicine, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".